The U.S. Securities and Exchange Commission added another set of charges against what it has called an insider trading ring led by Steven Fishoff, which has been alleged to have used information about a nonpublic licensing agreement between pharmaceutical companies to make illegal trades worth $1.5 million.

The latest charges allege that Winson Tang, a vice president at Sangamo BioSciences, tipped off a friend and business associate, Deshan Govender, about a coming licensing agreement between Sangamo and Biogen Idec. The deal would result in a collaboration to develop therapies for the treatment of certain illness.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]